Sensus Healthcare, Inc. (NASDAQ:SRTS) Shares Purchased by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership increased its stake in shares of Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) by 81.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 150,150 shares of the company's stock after purchasing an additional 67,269 shares during the quarter. Arrowstreet Capital Limited Partnership owned 0.92% of Sensus Healthcare worth $1,039,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. XTX Topco Ltd boosted its stake in shares of Sensus Healthcare by 76.0% in the 3rd quarter. XTX Topco Ltd now owns 31,530 shares of the company's stock valued at $183,000 after buying an additional 13,619 shares during the period. Geode Capital Management LLC grew its holdings in Sensus Healthcare by 8.5% during the 3rd quarter. Geode Capital Management LLC now owns 146,404 shares of the company's stock worth $849,000 after acquiring an additional 11,525 shares in the last quarter. Ritholtz Wealth Management grew its holdings in Sensus Healthcare by 65.3% during the 4th quarter. Ritholtz Wealth Management now owns 51,261 shares of the company's stock worth $355,000 after acquiring an additional 20,256 shares in the last quarter. Sigma Planning Corp purchased a new stake in shares of Sensus Healthcare in the 4th quarter valued at approximately $215,000. Finally, IFP Advisors Inc acquired a new stake in shares of Sensus Healthcare in the 4th quarter valued at $95,000. 25.30% of the stock is owned by institutional investors and hedge funds.

Sensus Healthcare Stock Performance

NASDAQ SRTS traded down $0.10 during trading hours on Thursday, hitting $4.62. The company had a trading volume of 27,009 shares, compared to its average volume of 308,480. The business has a 50 day moving average of $4.88 and a 200-day moving average of $6.42. The company has a market cap of $76.21 million, a PE ratio of 11.55 and a beta of 1.11. Sensus Healthcare, Inc. has a 1-year low of $3.13 and a 1-year high of $9.33.

Sensus Healthcare (NASDAQ:SRTS - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by ($0.01). Sensus Healthcare had a net margin of 15.90% and a return on equity of 12.60%. Sell-side analysts expect that Sensus Healthcare, Inc. will post 0.32 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. HC Wainwright reissued a "buy" rating and issued a $12.00 target price on shares of Sensus Healthcare in a report on Friday, April 4th. Lake Street Capital decreased their target price on Sensus Healthcare from $18.00 to $13.00 and set a "buy" rating for the company in a research note on Tuesday, March 11th.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.